News
-
-
-
-
-
-
PRESS RELEASE
Sandoz confirms regulatory approval for new semaglutide treatment option in Brazil, paving way to expand patient access
Sandoz receives regulatory approval for Owozy®, a new semaglutide treatment for type-2 diabetes in Brazil, enhancing patient access and supporting local healthcare systems -
-
-
PRESS RELEASE
Sandoz announces key leadership changes
Sandoz announces key leadership changes: Pascal Bouye appointed President, Generics Manufacturing & Supply; Glenn Gerecke takes on new role within the company. Keren Haruvi to oversee global M&A activities. Simon Goeller appointed Country President, Germany -
